January 2021

GASTROENTEROLOGY

ANTI-SIGLEC-8 ANTIBODY FOR EOSINOPHILIC GASTRITIS AND DUODENITIS

Featuring: Ikuo Hirano, MD and Nirmala Gonsalves, MD

Episode Summary

In this episode of the Better Edge podcast, Ikuo Hirano, MD, and Nirmala Gonsalves, MD, share details about a recent study published in the The New England Journal of Medicine that examines the use of a novel anti–Siglec-8 antibody known as AK002 for Eosinophilic Gastritis and Duodenitis. 
Ikuo Hirano, MD  is Professor of Medicine at Northwestern University Feinberg School of Medicine in the Division of Gastroenterology and Hepatology. He attended college at Yale University, medical school at the University of Pennsylvania and completed his medical residency and GI fellowship at Beth Israel Hospital in Boston. 
Nirmala Gonsalves, MD  is Professor of Medicine at Northwestern University Feinberg School of Medicine in the Division of Gastroenterology and Hepatology. Her focus of work is on Eosinophilic esophagitis, eosinophilic gastrointestinal disease, gastroesophageal reflux disease, esophageal disorders, food allergy and gastrointestinal disease, celiac disease, and general gastroenterology.

Refer a Patient

Northwestern Medicine welcomes the opportunity to partner with you in caring for your patients. ​

You May Also Like